BRAF V600E mutation is a predictive indicator of upfront chemotherapy for stage IV colorectal cancer

In stage IV colorectal cancer (CRC), initial resection of the primary tumor is considered to be an important strategy for improving disease outcome. However, there is no consensus on the timing as to when the surgical intervention of the primary tumor should occur. The present study hypothesizes tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Morikawa, Tatsuya, Inada, Ryo, Nagasaka, Takeshi, Mori, Yoshiko, Kishimoto, Hiroyuki, Kawai, Takashi, Umeda, Yuzo, Mishima, Hideyuki, Goel, Ajay, Fujiwara, Toshiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776948/
https://www.ncbi.nlm.nih.gov/pubmed/29434925
http://dx.doi.org/10.3892/ol.2017.7553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776948/
https://www.ncbi.nlm.nih.gov/pubmed/29434925
http://dx.doi.org/10.3892/ol.2017.7553

Ejemplares similares